Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
Abstract
The present disclosure provides methods, reagents, systems, and devices that target β lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure relates to methods and compositions for the detection of specific β-lactamase protein and nucleic acid sequences to indicate the presence of tuberculosis-complex bacteria.
Subject
G01N 33/573C07K 16/1289
C07K 16/40
C12N 9/86
C12Q 1/04
C12Q 1/689
C12Y 305/02006
G01N 33/5695
G01N 33/6854
C07K 2317/33
G01N 2333/35
G01N 2333/986
G01N 2469/10
G01N 2800/52
Collections
Citation
Cirillo, Jeffrey D.; Norman, Michael T. (2019). Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from https : / /hdl .handle .net /1969 .1 /177277.